N/A
N=25
Evaluation of New Fitting Characteristics for Extended Wear Hearing Aid Technology
Hearing Loss
Bottom Line
View on ClinicalTrials.gov: NCT05274165 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcome: Primary: Trial to Success Rate — 2; 0 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lyric Hearing Aid- Experimental Design (Device); Lyric Hearing Aid- Commercially Available (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Sonova AG
- Primary completion
- Sep 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Trial to Success Rate |
2; 0 | — |
Summary
Two groups of hearing aid candidates will be fit with extended wear technology. One group will be fit with the commercially available models, and the other group will be fit with either the commercially available model or a new model with different fitting characteristic.
After an appropriate trial period, the success rate of each group will be determined by the desire to purchase devices.
Eligibility Criteria
Inclusion Criteria
- Mild to moderate hearing loss
- New hearing aid users with no previous hearing aid experience interested in trying Lyric devices
- Must meet Lyric candidacy (see exclusion criteria)
Exclusion Criteria
- middle ear disease, including but not limited to history of tympanic membrane perforations, chronic otitis media, cholesteatoma, PE tubes
- radiation therapy to head or neck area
- participants who need regular MRI testing
- participants who regularly scuba dive or swim underwater
Data sourced from ClinicalTrials.gov (NCT05274165). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.